Gene · 104
Papers2,137
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 2,137
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Four Types of RNA Modification Writer-Related lncRNAs Are Effective Predictors of Prognosis and Immunotherapy Response in Serous Ovarian Carcinoma. | Front Immunol | 2022 | 35585970 | PubTator, text mining | PubMed |
| Aqueous Lumican Correlates with Central Retinal Thickness in Patients with Idiopathic Epiretinal Membrane: A Proteome Study. | Dis Markers | 2022 | 35571611 | PubTator, text mining | PubMed |
| Circular RNA (circ)_0129047 upregulates bone morphogenetic protein receptor type 2 expression to inhibit lung adenocarcinoma progression by sponging microRNA (miR)-1206. | Bioengineered | 2022 | 35570745 | PubTator, text mining | PubMed |
| Multiomic Profiling Identified EGF Receptor Signaling as a Potential Inhibitor of Type I Interferon Response in Models of Oncolytic Therapy by Vesicular Stomatitis Virus. | Int J Mol Sci | 2022 | 35563635 | PubTator, text mining | PubMed |
| Interplay between A-to-I Editing and Splicing of RNA: A Potential Point of Application for Cancer Therapy. | Int J Mol Sci | 2022 | 35563631 | PubTator, text mining | PubMed |
| HPV16 and HPV18 Genome Structure, Expression, and Post-Transcriptional Regulation. | Int J Mol Sci | 2022 | 35563334 | PubTator, text mining | PubMed |
| Brain Epitranscriptomic Analysis Revealed Altered A-to-I RNA Editing in Septic Patients. | Front Genet | 2022 | 35559016 | PubTator, text mining | PubMed |
| Regulation of A-to-I RNA editing and stop codon recoding to control selenoprotein expression during skeletal myogenesis. | Nat Commun | 2022 | 35523818 | PubTator, text mining | PubMed |
| Breakage of cytoplasmic chromosomes by pathological DNA base excision repair. | Nature | 2022 | 35477155 | PubTator, text mining | PubMed |
| Epitranscriptomic dynamics in brain development and disease. | Mol Psychiatry | 2022 | 35474104 | PubTator, text mining | PubMed |
| Oligonucleotide-directed RNA editing in primates. | Mol Ther | 2022 | 35460609 | PubTator, text mining | PubMed |
| CRISPR-Based Genome Editing: Advancements and Opportunities for Rice Improvement. | Int J Mol Sci | 2022 | 35457271 | PubTator, text mining | PubMed |
| Self or Non-Self? It Is also a Matter of RNA Recognition and Editing by ADAR1. | Biology (Basel) | 2022 | 35453767 | PubTator, text mining | PubMed |
| Cross talk between RNA modification writers and tumor development as a basis for guiding personalized therapy of gastric cancer. | Hum Genomics | 2022 | 35449086 | PubTator, text mining | PubMed |
| Current Status of Epitranscriptomic Marks Affecting lncRNA Structures and Functions. | Noncoding RNA | 2022 | 35447886 | PubTator, text mining | PubMed |
α-Amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptor and RNA processing gene dysregulation are early determinants of selective motor neuron vulnerability in a mouse model of amyotrophic lateral sclerosis. | Brain Commun | 2022 | 35445192 | PubTator, text mining | PubMed |
| Environmental induced transgenerational inheritance impacts systems epigenetics in disease etiology. | Sci Rep | 2022 | 35440735 | PubTator, text mining | PubMed |
| Epoxiconazole alters the histology and transcriptome of mouse liver in a transgenerational pattern. | Chem Biol Interact | 2022 | 35436446 | PubTator, text mining | PubMed |
| Cas13d: A New Molecular Scissor for Transcriptome Engineering. | Front Cell Dev Biol | 2022 | 35433685 | PubTator, text mining | PubMed |
| miR-589-3p promoted osteogenic differentiation of periodontal ligament stem cells through targeting ATF1. | J Orthop Surg Res | 2022 | 35399081 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/104/papers?page=23